Vincent Boland: Pfizer’s activist investor adds insult to injury for an ailing pharma giant

Pfizer was riding high during the pandemic but has been overtaken by rivals including Eli Lilly and Novo Nordisk whose weight loss drugs have left...

© The Business Post